GLP-1RA therapy has shown potential benefits in reducing the risk of major adverse cardiovascular events and improving kidney outcomes in patients with diabetes at high risk for cardiovascular disease
Two brand names, one molecule
Gastrointestinal adverse events, including diarrhoea, nausea, and vomiting, were consistently the most common side effects reported across all dose groups in the phase 2 trial
But if the early data holds, then I'm very optimistic," Doustdar said.
This may take two to five minutes for complete dissolution
Liraglutide at 10 nM and 100 nM also promoted osteogenic differentiation in hBMSC and Human dental pulp stem cells (hDPSC) through enhancing ALP activity, mineralization and osteogenic marker expression [21, 27]